Effects of nicorandil on myocardial infarct size in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: study design and protocol for the randomized controlled trial

Xiao-Si JIANG; Li-Chao TIAN; Zi-Chao JIANG; Yu-Ting ZOU; Ping LI; Xin-Chun YANG; Xi SU; Jin-Wen TIAN; Bei SHI; Zong-Zhuang LI; Yong-Jun LI; Ren-Qiang YANG; Geng QIAN; Yun-Dai CHEN

doi:10.11909/j.issn.1671-5411.2020.08.002

🤖This page has been translated by AI and may contain inaccuracies. Please refer to the original content for clarification.

Home>Articles>Effects of nicorandil on myocardial infarct size in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: study design and protocol for the randomized controlled trial

DOI: 10.11909/j.issn.1671-5411.2020.08.002

Effects of nicorandil on myocardial infarct size in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: study design and protocol for the randomized controlled trial

Xiao-Si JIANG

Li-Chao TIAN

Zi-Chao JIANG

Yu-Ting ZOU

Ping LI

Xin-Chun YANG

Xi SU

Jin-Wen TIAN

Bei SHI

Zong-Zhuang LI

Yong-Jun LI

Ren-Qiang YANG

Geng QIAN

Yun-Dai CHEN

Keywords：Cardiovascular diseaseMyocardial infarct sizeNicorandilPrimary percutaneous coronary interventionST-segment elevation myocardial infarction

Publication Date：2020-08-28

Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)

Pages：6( 519-524 )

Journal of Geriatric Cardiology

SCICSCD

ISSN：1671-5411

Year, Vol.(Issue)：2020,17(8)